Clinical Trial Update: The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases

View source ↗

Summary

The study reports biodistribution data for the PET radiotracer [18F]L-FAC in healthy subjects and in patients with cancer, autoimmune and inflammatory diseases,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Cancer

Drugs mentioned

• [18F]L-FAC (1-L-(2-Deoxy-2-18-Fluoroarabinofuranosyl) Cytosine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Autoimmune Diseases, Cancer | Status: COMPLETED